LEE ROSEBUSH [Tape]: If you take a look really at Novo's own February 2025 SEC filings, Novo themselves stated that the "supply constraints," and, another quote, "drug shortage notifications will continue into the foreseeable future," and we know based on patient reports and industry data, but there continues to be a shortage
Post-cycle: Many of the BDNF-driven neuroplastic changes persist beyond the active cycle
All from a single medication class
The water year restarts every year on October 1 and measures the rain totals for the season through the following September
The Science of the GLP-1 "Super Responders" In the rapidly evolving landscape of weight loss medications, a new term has moved from clinical journals to viral social media: the "Super Responder." While medications like Wegovy and Zepbound are effective for the majority of users, a specific subset of patients experiences weight loss that far exceeds clinical averages